BIOTRANSFORMATION OF SULINDAC IN END-STAGE RENAL-DISEASE

被引：13

作者：

GIBSON, TP

DOBRINSKA, MR

LIN, JH

ENTWISTLE, LA

DAVIES, RO

机构：

[1] NORTHWESTERN UNIV,NW MEM HOSP,SCH MED,NEPHROL HYPERTENS SECT,CHICAGO,IL 60611

[2] NORTHWESTERN UNIV,NW MEM HOSP,SCH MED,DEPT MED,CHICAGO,IL 60611

[3] VET ADM LAKESIDE MED CTR,CHICAGO,IL 60611

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1987年 / 42卷 / 01期

关键词：

D O I：

10.1038/clpt.1987.112

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：82 / 88

页数：7

共 13 条

[1] BILIARY-SECRETION OF SULINDAC AND METABOLITES IN MAN [J].

DOBRINSKA, MR ;

FURST, DE ;

SPIEGEL, T ;

VINCEK, WC ;

TOMPKINS, R ;

DUGGAN, DE ;

DAVIES, RO ;

PAULUS, HE .

BIOPHARMACEUTICS & DRUG DISPOSITION, 1983, 4 (04) :347-358

[2]

DUGGAN DE, 1977, J PHARMACOL EXP THER, V201, P8

[3] COMPARATIVE DISPOSITION OF SULINDAC AND METABOLITES IN 5 SPECIES [J].

DUGGAN, DE ;

HOOKE, KF ;

NOLL, RM ;

HUCKER, HB ;

VANARMAN, CG .

BIOCHEMICAL PHARMACOLOGY, 1978, 27 (19) :2311-2320

[4]

DUGGAN DE, 1977, CLIN PHARMACOL THER, V21, P326

[5] ENTEROHEPATIC CIRCULATION OF SULINDAC AND METABOLITES [J].

DUJOVNE, CA ;

PITTERMAN, A ;

VINCEK, WC ;

DOBRINSKA, MR ;

DAVIES, RO ;

DUGGAN, DE .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (02) :172-177

[6]

HUCKER HB, 1973, DRUG METAB DISPOS, V1, P721

[7]

Kwan K C, 1977, Acta Rhumatol Belg, V1, P168

[8]

KWAN KC, 1980, CURRENT CONCEPTS ANT, P69

[9]

LIN JH, 1985, DRUG METAB DISPOS, V13, P608

[10]

LIN JH, 1985, DRUG METAB DISPOS, V13, P602

← 1 2 →